A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 400 participants.
Also called NCT07220538
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT07220538 -
ChiCTR2500107051
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07220538. Randomized; no masking; primary purpose treatment. Start 2025-11-28 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment
- Acronym
- GiCIIS
- Condition
- Ischemic Stroke Hospitalized
- Condition
- Impairment, Cognitive
- Intervention (Drug)
- Extract of Ginkgo Biloba Leaves Tablets 240 mg (2 x 40 mg, t.i.d.)
- Intervention (Other)
- Standard of care (SoC) Group
- Lead sponsor
- Dr. Willmar Schwabe GmbH & Co. KG
- Collaborator
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct07220538- Content hash
84372440740eb69270e29b230765606b9f774d31021e796dc8620796c6baf497